Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats (Q46857146)

25 December 2017

title

Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats (English)

1 reference

25 December 2017

author name string

Rocco Barazzoni

1

1 reference

25 December 2017

Michela Zanetti

2

1 reference

25 December 2017

Maria Rosa Cattin

3

1 reference

25 December 2017

Luca Visintin

4

1 reference

25 December 2017

Pierandrea Vinci

5

1 reference

25 December 2017

Luigi Cattin

6

1 reference

25 December 2017

Marco Stebel

7

1 reference

25 December 2017

Gianfranco Guarnieri

8

1 reference

25 December 2017

publication date

1 November 2007

1 reference

25 December 2017

published in

Obesity

1 reference

25 December 2017

volume

15

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

page(s)

2614-2623

1 reference

25 December 2017

A role for ghrelin in the central regulation of feeding

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin causes hyperphagia and obesity in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin induces adiposity in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin response following a period of acute overfeeding in normal weight men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Circulating ghrelin levels are decreased in human obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Skeletal muscle mitochondrial protein metabolism and function in ageing and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Direct effect of ghrelin on leptin production by cultured rat white adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

From receptor to transporter: insulin signalling to glucose transport.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle--tissue-specific impact on tissue triglyceride content and AKT activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Interorgan signaling between adipose tissue metabolism and skeletal muscle uncoupling protein homologs: is there a role for circulating free fatty acids?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Glucose utilization and insulin action in adult rats submitted to prolonged food restriction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Cerebrospinal fluid ghrelin is negatively associated with body mass index.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin action in the brain controls adipocyte metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Fasting in healthy individuals and adaption to undernutrition during chronic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Dose-dependent inhibition by ghrelin of insulin secretion in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Leptin downregulates ghrelin levels in streptozotocin-induced diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.313

1 reference

25 December 2017

PubMed ID

18070752

1 reference

25 December 2017